Drug Approval | March 02, 2024
Aurobindo Pharma receives USFDA approval for Fingolimod Capsules, 0.5 mg
The product will be launched in March 2024
The product will be launched in March 2024
Eugia Pharma Specialities restarts production at terminally sterilized product lines
_in_Mizushima,_Japan_256_384.jpg)
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
The observations do not pose any risk to site's compliance standards or its business continuity
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
The restructuring aims to create synergies across the business and strengthen capital structure
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
Subscribe To Our Newsletter & Stay Updated
